• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Aurobindo Pharma Limited — Updates, 26-02-2026: Press Release

    26-02-2026 | 11:47 am

    Aurobindo's Eugia Pharma received USFDA approval for Everolimus Tablets, targeting a US$78 million (~7.8 Cr) market. Launch is expected next financial year. This marks Eugia's 184th ANDA approval, expanding its specialty product portfolio.

    No comments yet. Be the first to comment!

    All announcements from Aurobindo Pharma Limited